Type 1 Interferon Signature in the Scalp Lesions of Alopecia Areata

    March 2010 in “ British Journal of Dermatology
    Mehran Ghoreishi, Magdalena Martinka, Jan P. Dutz
    Image of study
    TLDR Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.
    The study examined the presence of type 1 interferon-related proteins in scalp lesions of patients with alopecia areata (AA) and compared them to other scalp conditions. Scalp biopsies from 6 patients with inflammatory AA, 2 with non-inflammatory AA, 2 with discoid lupus erythematosus (DLE), 2 with lichen planopilaris (LPP), and 2 with androgenetic alopecia were analyzed for the expression of myxovirus protein A (MxA), CXCR3, granzyme B (GrB), and T-cell intracytoplasmic antigen 1 (TiA-1). The results showed that MxA was expressed in inflammatory AA similar to cicatricial alopecia but not in non-inflammatory AA or androgenetic alopecia. CXCR3-expressing cells correlated with MxA expression, and AA lesions had fewer GrB+ cells and more TiA-1+ cells compared to cicatricial alopecia. The study concluded that AA features a type 1 interferon signature and differs from cicatricial alopecia in the pattern of interferon signature and cytotoxic proteins, suggesting AA is a cytotoxic assault on the hair follicle. Treatments that induce type 1 IFN were found ineffective for AA, indicating that targeting the IFN-α pathway may be a potential therapeutic approach.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 1000+ results

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 2 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community DHT and 5AR respect post, it's importance within the brain

      in Research/Science  111 upvotes 8 months ago
      The conversation discusses whether to use finasteride for hair loss, considering its role in inhibiting DHT and 5AR, which can affect brain function and mood. Some users report anxiety and depression from finasteride, while others do not experience these side effects and emphasize the importance of DHT for brain and prostate health.

    Related Research

    3 / 3 results